scholarly journals Disclosing HIV-Positive Status: What Do Questions Have to Do with It?

2020 ◽  
Vol 9 (1) ◽  
pp. 1-8
Author(s):  
Jacinta Wanjiku Kiranga ◽  
Masibo F. P. Lumala ◽  
Musebe Richard
Keyword(s):  
Communication Skill ◽  
Psychological Safety ◽  
Hiv Disclosure ◽  
Hiv Positive ◽  
People Living With Hiv ◽  
Care Centre ◽  
Treatment Support ◽  
Living With Hiv ◽  
Depth Interviews ◽  
Prevention Of Hiv

This article discussed the need to ask questions among people living with HIV to facilitate disclosure. This is because disclosure of a HIV-positive status is an important tool for prevention of HIV and early treatment, many people who know their status do not disclose to their spouse or sexual partners. Disclosure would not only protect the spouse from risk of infection and if already infected be able to access treatment, support and care  but also promote adherence to antiretroviral therapy. The paper looked at questioning as an important communication skill that can facilitate disclosure. This paper is based on a larger qualitative study that investigated the factors influencing disclosure of HIV-positive status to spouses among people living with HIV in Kirinyaga County in Kenya. Data was collected using semistructured In-Depth Interviews. The paper argued that questions play a crucial role in disclosure of a HIV-positive status in accessing information which would otherwise be unavailable about the HIV-positive status of their spouses and suggests incorporation of communication skills on questioning and disclosure at the comprehensive care  Centre services. Key Words: HIV disclosure, person living with HIV, questioning, spouses, psychological safety

scholarly journals Studi Literatur: Hubungan Pengetahuan dengan Stigma pada Penderita HIV/AIDS (ODHA)

2021 ◽  
Vol 7 (1) ◽  
pp. 21
Author(s):  
Nila Alfiani ◽  
Ahmad Rido'i Yuda Prayogi ◽  
Ayik Mirayanti Mandagi ◽  
Diansanto Prayoga
Keyword(s):  
Systematic Review ◽  
Hiv Positive ◽  
People Living With Hiv ◽  
Systematic Review Methods ◽  
Hiv Virus ◽  
The World ◽  
Living With Hiv ◽  
The Relationship ◽  
Prevention Of Hiv ◽  
Hiv Aids

HIV/AIDS is a disease that has become a pandemic and worries people all over the world, because until now there has not been found a vaccine or drug for the prevention of HIV/AIDS. HIV positive cases in Indonesia from year to year have increased. The problems faced by people with HIV/AIDS are very complex. Every day the patient's condition will get weaker if he does not take medication regularly because the HIV virus will attack the patient's immune system. In addition, the stigma and discrimination of the surrounding community are also a burden that must be borne by people with HIV AIDS. The stigma makes HIV sufferers worse, with this stigma, HIV sufferers are ashamed to seek treatment at a health service. This writing is to determine the relationship between knowledge and stigma against people living with HIV/AIDS (PLWHA) through a review of various literature with the same theme. The method used in this paper uses rivew literature. This type of research uses systematic review. The study design used retrospective, prospective and systematic review methods. There is a relationship between knowledge and stigma against PLWHA. People with low knowledge tend to stigmatize people with HIV.

The Bio/Necropolitics of ACTG 076: Lessons from Pregnant Women of Colour Living with HIV for Treatment for Prevention in the Twenty-first Century

Somatechnics ◽  
2020 ◽  
Vol 10 (2) ◽  
pp. 233-253
Author(s):  
Eli Manning
Keyword(s):  
Hiv Transmission ◽  
Ethical Dilemmas ◽  
Hiv Treatment ◽  
First Century ◽  
Hiv Positive ◽  
Treatment As Prevention ◽  
People Living With Hiv ◽  
Hiv Positive Women ◽  
Aids Clinical Trials ◽  
Living With Hiv

Since the pharmaceutical turn, using HIV treatment to prevent transmission is increasingly common. Treatment as Prevention®, or TasP, has relied on HIV treatment to prevent HIV transmission, targeting people living with HIV. However, TasP is predicated on troublesome heterosexist, classist, and racist medical practices borrowed from various times and spaces that enact biopolitical and necropolitical relations. This paper discusses the debate surrounding the first clinical trial that used HIV treatment to prevent transmission from woman-to-foetus. The 1994 landmark AIDS Clinical Trials Group 076 study laid the groundwork for using HIV treatment to prevent HIV transmission, the essential precursor to TasP. By examining the concerns of HIV positive women of colour and other AIDS activists, we are able to understand the ethical dilemmas and practical consequences that still haunt today's game-changing uses of HIV treatment for prevention and to see how biopolitics and necropolitics persist in TasP.

Assessing psychological symptom networks related to HIV-positive duration among people living with HIV: a network analysis

AIDS Care ◽  
2021 ◽  
pp. 1-9
Author(s):  
Zheng Zhu ◽  
Mengdi Guo ◽  
Tingyue Dong ◽  
Shuyu Han ◽  
Yan Hu ◽  
...  
Keyword(s):  
Network Analysis ◽  
Psychological Symptom ◽  
Hiv Positive ◽  
People Living With Hiv ◽  
Living With Hiv

scholarly journals Differential relationships of stress and HIV disclosure by gender: a person centered longitudinal study

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Chengbo Zeng ◽  
Shan Qiao ◽  
Xiaoming Li ◽  
Xueying Yang ◽  
Zhiyong Shen ◽  
...  
Keyword(s):  
Multinomial Logistic Regression ◽  
Growth Mixture Modeling ◽  
Hiv Disclosure ◽  
Lower Probability ◽  
People Living With Hiv ◽  
Target Number ◽  
Cross Sectional ◽  
Growth Mixture ◽  
Cross Sectional Design ◽  
Living With Hiv

Abstract Background Existing literature mostly consider HIV disclosure as a static event and investigate its relationship with stress using a cross-sectional design. It is unclear about the dynamic changes of HIV disclosure levels (defined as the number of disclosure targets) and how stress may influence these changes. This study explored different disclosure levels using a person-centered longitudinal approach, examined whether stress could predict these disclosure levels, and investigated if this relationship differed by gender among people living with HIV (PLWH). Methods Data were derived from a prospective cohort study conducted from November 2016 to January 2018 in Guangxi, China. Four hundred forty-four PLWH were included. Participants were assessed on perceived stress, sociodemographic characteristics, and number of HIV disclosure targets at baseline, 6-month, and 12-month follow-ups. Growth mixture modeling was used to characterize disclosure levels based on the changes of disclosure target number. Multinomial logistic regression was used to predict disclosure levels with baseline stress after adjusting for covariates. The interaction effect of stress by gender was examined. Adjusted odds ratio (AOR) with its 95% confidence interval were reported to show the strength of association.  Results Three levels of disclosure were characterized as “Low levels of disclosure” (Level One), “Increased levels of disclosure” (Level Two), and “High levels of disclosure” (Level Three). Accordingly, 355 (81.2%), 28 (6.4%), and 64 (12.4%) of PLWH were categorized respectively under low, increased, and high levels of disclosure. The interaction of baseline stress by gender was significant in differentiating Level One from Three (AOR = 0.85 [0.74 ~ 0.99]) while it was not significant between Level One and Two (AOR = 0.96 [0.81 ~ 1.15]). Compared to female, male PLWH with higher baseline stress had lower probability to have consistent high disclosure levels over time. PLWH who were married/cohabited had lower probability of being classified into consistent high levels of disclosure than low level (AOR = 0.43 [0.19 ~ 0.94]). Conclusions There was gender difference in the relationship between stress and levels of HIV disclosure. To promote HIV disclosure, gender tailored interventions should be employed to help PLWH cope with stress.

scholarly journals Food consumption and nutritional status of people living with HIV/AIDS (PLWHA): a case of Thika and Bungoma Districts, Kenya

2009 ◽  
Vol 13 (4) ◽  
pp. 475-479 ◽  
Author(s):  
Elizabeth Nafula Kuria
Keyword(s):  
Nutritional Status ◽  
Food Consumption ◽  
Dietary Habits ◽  
Well Being ◽  
Hiv Positive ◽  
People Living With Hiv ◽  
Cross Sectional ◽  
Significant Difference ◽  
Living With Hiv ◽  
Hiv Aids

AbstractObjectiveTo establish the food consumption, dietary habits and nutritional status of people living with HIV/AIDS (PLWHA) and adults whose HIV status is not established.DesignCross-sectional descriptive survey.SettingThika and Bungoma Districts, Kenya.SubjectsA random sample of 439 adults; 174 adults living with HIV/AIDS and 265 adults whose HIV/AIDS status was not established in Thika and Bungoma Districts.ResultsMajority of PLWHA consume foods that are low in nutrients to build up the immune system and help maintain adequate weight, and there is little variety in the foods they consume. More adults who are HIV-positive are undernourished than those whose status is not established. Of the HIV-positive adults, those with a BMI of ≤18·5 kg/m2 were 23·6 % (Thika 20·0 % and Bungoma 25·7 %) while of the adults whose status is not established those with BMI ≤ 18·5 kg/m2 were 13·9 % (Thika 9·3 % and Bungoma 16·7 %).ConclusionsAdults who are HIV-positive are more likely to be undernourished than those whose status is not established, as there is a significant difference (P = 0·000) between the nutritional status (BMI) of PLWHA and those whose HIV/AIDS status is not established. PLWHA consume foods that are low in nutrients to promote their nutritional well-being and health.

scholarly journals Longitudinal Analysis of HIV Disclosure Intention: The Implication of Duration of Diagnosis Knowledge and CD4 Counts Among Asymptomatic Treatment-seeking People Living with HIV/AIDS

2020 ◽  
Vol 14 (1) ◽  
pp. 84-89
Author(s):  
A. O. Olaseni
Keyword(s):  
Immune Deficiency Syndrome ◽  
Hiv Treatment ◽  
Hiv Disclosure ◽  
World Health ◽  
Treatment Seeking ◽  
Hiv Positive ◽  
People Living With Hiv ◽  
Self Disclosure ◽  
Cd4 Counts ◽  
Hiv Aids

Introduction: The spate of non-disclosure among individuals diagnosed with Human-Immunodeficiency-Virus and Acquired-Immune-Deficiency-Syndrome (HIV/AIDS) has continually been a primary global concern, especially in developing countries. Meta-analysis findings in Nigeria reported poor disclosure rates of 12.5% - 39.5%, which were far below the average disclosure benchmark of 79.0% standard stipulated for developing nations by the World Health Organization. There is no consensus regarding the roles of CD4 counts in disclosure intention. In Nigeria, there is a paucity of literature providing detailed understanding of the predictors of disclosure intention by the duration of diagnosis knowledge and CD4 counts. Methods: This study, therefore, investigated the implication of duration of diagnosis knowledge and CD4 counts in the prediction of HIV disclosure intention among people seeking HIV treatment. Longitudinal survey research designs were adopted. 390 participants were purposively selected to respond to HIV Self-Disclosure Intention Index (α=0.92), while information on CD4 counts and Duration of Diagnosis Knowledge was obtained from the selected respondents’ case files periodically. Binomial logistic regression analysis was used to analyze data at 0.05. Respondents’ mean age was 39.5±10.5 years. Results: Findings revealed that the duration of diagnosis knowledge and CD4 counts interactively predicted the outcome of disclosure intention among treatment-seeking PLHIV. (χ2 = 12.78, df = 2, p < 0.001) and further showed that the likelihood of disclosing HIV positive status increases by 13% between Time 1 (OR = -0.49, p < 0.01; 95%CI = 01.14-12.74) and Time 2 (OR = -0.36, p < 0.05; 95%CI = 01.11-10.93). Increase in CD4 counts was also found to increase the likelihood of HIV self-disclosure by 15% between Time 1 (OR = - 0.84, p < 0.01; 95%CI = 01.09-03.06) and Time 2 (OR = - 0.99, p < 0.01; 95%CI = 00.29-03.06). Conclusion: It was concluded that the duration of diagnosis knowledge and CD4 counts have significant implications in determining the intention to disclose HIV positive status. The study limitations and recommendations were further discussed.

scholarly journals Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV

2022 ◽  
Vol 14 (1) ◽  
pp. 43-55
Author(s):  
Cristina Micali ◽  
Ylenia Russotto ◽  
Grazia Caci ◽  
Manuela Ceccarelli ◽  
Andrea Marino ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Overall Survival ◽  
Cancer Staging ◽  
Hiv Positive ◽  
People Living With Hiv ◽  
Liver Cancers ◽  
Significant Difference ◽  
Cancer Specific Mortality ◽  
Living With Hiv ◽  
Hiv Negative

Hepatocellular carcinoma (HCC) accounts for approximately 75–90% of primary liver cancers and is the sixth most common cancer and the third leading cause of cancer-related deaths worldwide. In the HIV-positive population, the risk of HCC is approximately four times higher than in the general population, with higher cancer-specific mortality than in HIV-negative patients. In most cases, HCC diagnosis is made in patients younger than the HIV-negative population and in the intermediate-advanced stage, thus limiting the therapeutic possibilities. Treatment choice in HIV-positive patients with HCC is subject to cancer staging, liver function and health status, as for HIV-negative and non-HIV-negative HCC patients. There are relatively few studies on the efficacy and safety in HIV-positive patients to date in loco-regional treatments for HCC. So far, literature shows that curative treatments such as radiofrequency ablation (RFA) have no significant differences in overall survival between HIV-positive and HIV-negative patients, as opposed to palliative treatments such as TACE, where there is a significant difference in overall survival. Although it can be assumed that the most recently discovered loco-regional therapies are applicable to HIV-positive patients with HCC in the same way as HIV-negative patients, further studies are needed to confirm this hypothesis. The purpose of our review is to evaluate these treatments, their efficacy, effectiveness, safety and their applicability to HIV-positive patients.

Sign in / Sign up

Export Citation Format

Share Document